{
    "text_blocks": {
        "data": {
            "block_count": 9,
            "table_index": 0
        },
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "votes": {
                    "0": "0",
                    "1": "0",
                    "2": "0"
                },
                "decision": "0"
            },
            "gpt-4o-2024-08-06": {
                "votes": null,
                "decision": null
            }
        },
        "timestamp": "2025-01-21_09-36-59"
    },
    "table_comments": {
        "data": "CONSOLIDATED BALANCE SHEETS\tDecember 31,\t(in millions, except per share amounts)\t2022\t2021\t",
        "timestamp": "2025-03-11_12-27-20"
    },
    "units": {
        "data": {
            "sum_units": 1000000,
            "sum_divider": 1.0
        },
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "votes": {
                    "0": "1000000",
                    "1": "1000000"
                },
                "decision": "1000000"
            },
            "gpt-4o-2024-08-06": {
                "votes": null,
                "decision": null
            }
        },
        "timestamp": "2025-03-11_12-27-23"
    },
    "post_table_text": {
        "data": "\tSee accompanying notes.\t48\tGILEAD SCIENCES, INC.\tCONSOLIDATED STATEMENTS OF INCOME\tYear En",
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "trials": {
                    "0": "'\tSee accompanying notes.\t48\tGILEAD SCIENCES, INC.\tCONSOLIDATED STATEMENTS OF INCOME\tYear En'"
                },
                "decision": "'\tSee accompanying notes.\t48\tGILEAD SCIENCES, INC.\tCONSOLIDATED STATEMENTS OF INCOME\tYear En'"
            },
            "gpt-4o-2024-08-06": {
                "trials": {},
                "decision": null
            }
        },
        "timestamp": "2025-03-11_12-27-25"
    },
    "table_body": {
        "data": "Assets\tCurrent assets:\tCash and cash equivalents\t$\t5,412\t$\t5,338\tShort-term marketable debt securities\t973\t1,182\tAccounts receivable, net\t4,777\t4,493\tInventories\t1,507\t1,618\tPrepaid and other current assets\t1,774\t2,141\tTotal current assets\t14,443\t14,772\tProperty, plant and equipment, net\t5,475\t5,121\tLong-term marketable debt securities\t1,245\t1,309\tIntangible assets, net\t28,894\t33,455\tGoodwill\t8,314\t8,332\tOther long-term assets\t4,800\t4,963\tTotal assets\t$\t63,171\t$\t67,952\tLiabilities and Stockholders  Equity\tCurrent liabilities:\tAccounts payable\t$\t905\t$\t705\tAccrued rebates\t3,479\t3,244\tOther current liabilities\t4,580\t6,145\tCurrent portion of long-term debt and other obligations, net\t2,273\t1,516\tTotal current liabilities\t11,237\t11,610\tLong-term debt, net\t22,957\t25,179\tLong-term income taxes payable\t3,916\t4,767\tDeferred tax liability\t2,673\t4,356\tOther long-term obligations\t1,179\t976\tCommitments and contingencies (Note 13)\tStockholders  equity:\tPreferred stock, par value $\t0.001\tper share;\t5\tshares authorized;\tno\tne outstanding\t \t \tCommon stock, par value $\t0.001\tper share;\t5,600\tauthorized;\t1,247\tand\t1,254\tshares issued and outstanding, respectively\t1\t1\tAdditional paid-in capital\t5,550\t4,661\tAccumulated other comprehensive income\t2\t83\tRetained earnings\t15,687\t16,324\tTotal Gilead stockholders  equity\t21,240\t21,069\tNoncontrolling interest\t(\t31\t)\t(\t5\t)\tTotal stockholders  equity\t21,209\t21,064\tTotal liabilities and stockholders  equity\t$\t63,171\t$\t67,952",
        "timestamp": "2025-03-11_12-27-25"
    },
    "table_json_created": {
        "data": true,
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "trials": {
                    "0": "{\"Assets\": {\"Current assets\": {\"Cash and cash equivalents\": [5412, 5338], \"Short-term marketable debt securities\": [973, 1182], \"Accounts receivable, net\": [4777, 4493], \"Inventories\": [1507, 1618], \"Prepaid and other current assets\": [1774, 2141], \"Total current assets\": [14443, 14772]}, \"Property, plant and equipment, net\": [5475, 5121], \"Long-term marketable debt securities\": [1245, 1309], \"Intangible assets, net\": [28894, 33455], \"Goodwill\": [8314, 8332], \"Other long-term assets\": [4800, 4963], \"Total assets\": [63171, 67952]}, \"Liabilities and Stockholders Equity\": {\"Current liabilities\": {\"Accounts payable\": [905, 705], \"Accrued rebates\": [3479, 3244], \"Other current liabilities\": [4580, 6145], \"Current portion of long-term debt and other obligations, net\": [2273, 1516], \"Total current liabilities\": [11237, 11610]}, \"Long-term debt, net\": [22957, 25179], \"Long-term income taxes payable\": [3916, 4767], \"Deferred tax liability\": [2673, 4356], \"Other long-term obligations\": [1179, 976], \"Commitments and contingencies\": null, \"Stockholders equity\": {\"Preferred stock, par value $ 0.001 per share; 5 shares authorized; no shares outstanding\": [0, 0], \"Common stock, par value $ 0.001 per share; 5,600 authorized; 1,247 and 1,254 shares issued and outstanding, respectively\": [1, 1], \"Additional paid-in capital\": [5550, 4661], \"Accumulated other comprehensive income\": [2, 83], \"Retained earnings\": [15687, 16324], \"Total Gilead stockholders equity\": [21240, 21069], \"Noncontrolling interest\": [-31, -5], \"Total stockholders equity\": [21209, 21064]}, \"Total liabilities and stockholders equity\": [63171, 67952]}}"
                },
                "decision": "{\"Assets\": {\"Current assets\": {\"Cash and cash equivalents\": [5412, 5338], \"Short-term marketable debt securities\": [973, 1182], \"Accounts receivable, net\": [4777, 4493], \"Inventories\": [1507, 1618], \"Prepaid and other current assets\": [1774, 2141], \"Total current assets\": [14443, 14772]}, \"Property, plant and equipment, net\": [5475, 5121], \"Long-term marketable debt securities\": [1245, 1309], \"Intangible assets, net\": [28894, 33455], \"Goodwill\": [8314, 8332], \"Other long-term assets\": [4800, 4963], \"Total assets\": [63171, 67952]}, \"Liabilities and Stockholders Equity\": {\"Current liabilities\": {\"Accounts payable\": [905, 705], \"Accrued rebates\": [3479, 3244], \"Other current liabilities\": [4580, 6145], \"Current portion of long-term debt and other obligations, net\": [2273, 1516], \"Total current liabilities\": [11237, 11610]}, \"Long-term debt, net\": [22957, 25179], \"Long-term income taxes payable\": [3916, 4767], \"Deferred tax liability\": [2673, 4356], \"Other long-term obligations\": [1179, 976], \"Commitments and contingencies\": null, \"Stockholders equity\": {\"Preferred stock, par value $ 0.001 per share; 5 shares authorized; no shares outstanding\": [0, 0], \"Common stock, par value $ 0.001 per share; 5,600 authorized; 1,247 and 1,254 shares issued and outstanding, respectively\": [1, 1], \"Additional paid-in capital\": [5550, 4661], \"Accumulated other comprehensive income\": [2, 83], \"Retained earnings\": [15687, 16324], \"Total Gilead stockholders equity\": [21240, 21069], \"Noncontrolling interest\": [-31, -5], \"Total stockholders equity\": [21209, 21064]}, \"Total liabilities and stockholders equity\": [63171, 67952]}}"
            },
            "gpt-4o-2024-08-06": {
                "trials": {},
                "decision": null
            }
        },
        "timestamp": "2025-03-12_11-29-53"
    },
    "problems": {
        "data": [],
        "timestamp": "2025-03-12_11-29-53"
    }
}